Lúcia Silla

3PUBLICATIONS
2CO-AUTHORS
Innate immunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 02, 2023
Peripheral blood persistence and expansion of transferred non-genetically modified Natural Killer cells might not be necessary for clinical activity.

Lucia Silla

|Sep 07, 2021
Adoptive immunotherapy with double-bright (CD56bright /CD16bright ) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study.

Lucia Silla, Vanessa Valim, Annelise Pezzi

|Jul 10, 2020
Double-bright (CD56bright/CD16bright) natural killer cell adoptive immunotherapy for SARS-CoV-2.

Lúcia Silla

Pageof 1

Frequent Collaborators

1 joint publications

Annelise Pezzi

1 joint publications

Dean A Lee